Evolent Health, Inc. Deferred Revenue Recognized
Evolent Health, Inc. (EVH) reported Deferred Revenue Recognized of $696.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2026-08-06
- Evolent Health, Inc. contract with customer, liability, revenue recognized for the quarter ending 2026-03-31 was $614.00K, a 43.82% decline year-over-year.
- Evolent Health, Inc. contract with customer, liability, revenue recognized for the quarter ending 2025-03-31 was $1.09M, a 66.65% decline year-over-year.
- Evolent Health, Inc. contract with customer, liability, revenue recognized for the quarter ending 2024-03-31 was $3.28M, a 17.81% decline year-over-year.
- Evolent Health, Inc. contract with customer, liability, revenue recognized for the quarter ending 2023-03-31 was $3.99M, a 60.62% decline year-over-year.
- Evolent Health, Inc. contract with customer, liability, revenue recognized for fiscal 2025 was $1.92M, a 66.13% decline from fiscal 2024.
- Evolent Health, Inc. contract with customer, liability, revenue recognized for fiscal 2024 was $5.67M, a 1.22% decline from fiscal 2023.
- Evolent Health, Inc. contract with customer, liability, revenue recognized for fiscal 2023 was $5.74M, a 51.75% decline from fiscal 2022.
- Evolent Health, Inc. contract with customer, liability, revenue recognized for fiscal 2022 was $11.90M, a 16.96% increase from fiscal 2021.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 9 month | Contract with Customer, Liability, Revenue Recognized 12 month |
|---|---|---|---|---|
| 2026-06-30 | $696.00K 10-Q · filed 2026-08-06 | |||
| 2026-03-31 | $614.00K 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | $1.92M 10-K · filed 2026-02-25 | |||
| 2025-09-30 | $1.67M 10-Q · filed 2025-11-07 | |||
| 2025-06-30 | $1.47M 10-Q · filed 2025-08-11 | |||
| 2025-03-31 | $1.09M 10-Q · filed 2025-05-09 | |||
| 2024-12-31 | $5.67M 10-K · filed 2025-02-21 | |||
| 2024-09-30 | $5.04M 10-Q · filed 2024-11-08 | |||
| 2024-06-30 | $4.26M 10-Q · filed 2024-08-09 | |||
| 2024-03-31 | $3.28M 10-Q · filed 2024-05-10 | |||
| 2023-12-31 | $5.74M 10-K · filed 2024-02-23 | |||
| 2023-09-30 | $5.27M 10-Q · filed 2023-11-02 | |||
| 2023-06-30 | $4.72M 10-Q · filed 2023-08-03 | |||
| 2023-03-31 | $3.99M 10-Q · filed 2023-05-04 | |||
| 2022-12-31 | $11.90M 10-K · filed 2023-02-24 | |||
| 2022-09-30 | $11.45M 10-Q · filed 2022-11-03 | |||
| 2022-06-30 | $10.80M 10-Q · filed 2022-08-03 | |||
| 2022-03-31 | $10.12M 10-Q · filed 2022-05-05 | |||
| 2021-12-31 | $10.18M 10-K · filed 2022-02-24 | |||
| 2021-09-30 | $9.34M 10-Q · filed 2021-11-04 | |||
| 2021-06-30 | $8.73M 10-Q · filed 2021-08-05 | |||
| 2021-03-31 | $7.96M 10-Q · filed 2021-05-06 | |||
| 2020-12-31 | $18.48M 10-K · filed 2021-02-26 | |||
| 2020-09-30 | $17.42M 10-Q · filed 2020-11-06 | |||
| 2020-06-30 | $15.54M 10-Q · filed 2020-08-07 | |||
| 2020-03-31 | $12.53M 10-Q · filed 2020-05-28 | |||
| 2019-12-31 | $17.87M 10-K · filed 2020-03-02 | |||
| 2019-09-30 | $15.85M 10-Q · filed 2019-11-05 | |||
| 2019-06-30 | $12.71M 10-Q · filed 2019-08-09 | |||
| 2019-03-31 | $11.81M 10-Q · filed 2019-05-09 | |||
| 2018-12-31 | $19.30M 10-K · filed 2019-02-28 | |||
| 2018-09-30 | $3.70M 10-Q · filed 2018-11-08 | $17.00M 10-Q · filed 2018-11-08 | ||
| 2018-06-30 | $4.40M 10-Q · filed 2018-08-09 | $13.30M 10-Q · filed 2018-08-09 | ||
| 2018-03-31 | $8.80M 10-Q · filed 2018-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRANKLIN COVEY CO (FC) | United States | $0.195B | 123.76 |
| GARTNER INC (IT) | United States | $11.326B | 11.20 |